Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ARCT
Stock Latest News
Ratings
Arcturus Therapeutics: Promising Phase II Prospects for ARCT-032 in Cystic Fibrosis Amidst Regulatory Approvals
3d ago
ARCT
Premium
Ratings
Arcturus Therapeutics: Buy Rating Backed by Promising Vaccine Development and Strategic Advancements
9d ago
ARCT
Premium
The Fly
Arcturus Therapeutics granted fast track designation for ARCT-2304 from FDA
9d ago
ARCT
Premium
The Fly
Arcturus Therapeutics price target lowered to $45 from $71 at Guggenheim
9d ago
ARCT
Premium
Ratings
Optimistic Buy Rating for Arcturus Therapeutics Amid Promising Cystic Fibrosis Treatment Developments
18d ago
ARCT
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
29d ago
INO
ARCT
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
PLX
ANNX
Premium
Ratings
Strategic Growth and Financial Positioning: Arcturus Therapeutics’ Promising Outlook Amid Upcoming Trial Data and Financial Adjustments
1M ago
ARCT
Premium
Market News
Despite Revenue Setback, Arcturus Therapeutics (ARCT) Vaccine Breakthroughs Fuel Optimism
1M ago
ARCT
Premium
The Fly
Arcturus Therapeutics price target lowered to $68 from $74 at Canaccord
1M ago
ARCT
Premium
Market News
3 Best Stocks to Buy Now, 3/10/2025, According to Top Analysts
1M ago
ARCT
DOCU
Premium
Company Announcements
Arcturus Therapeutics’ Earnings Call: Mixed Outlook with Strategic Wins
1M ago
ARCT
Premium
The Fly
Arcturus Therapeutics price target lowered to $60 from $63 at H.C. Wainwright
1M ago
ARCT
Premium
Ratings
Positive Outlook for Arcturus Therapeutics: Strong Vaccine Sales and Promising Cystic Fibrosis Program Drive Buy Rating
1M ago
ARCT
Premium
Company Announcements
Arcturus Therapeutics Reports 2024 Financial Results and Pipeline Progress
1M ago
ARCT
Premium
The Fly
Arcturus Therapeutics reports Q4 EPS ($1.11), consensus (49c)
1M ago
ARCT
Premium
Pre-Earnings
ARCT Upcoming Earnings Report: What to Expect?
2M ago
ARCT
Premium
The Fly
Arcturus Therapeutics price target raised to $48 from $41 at BTIG
2M ago
ARCT
Premium
Ratings
Arcturus Therapeutics: Buy Rating Affirmed on EU Approval and Promising Clinical Data for Kostaive Vaccine
2M ago
ARCT
Premium
The Fly
Arcturus Therapeutics and CSL’s Kostaive COVID-19 vaccine approved in Europe
2M ago
ARCT
Premium
The Fly
CSL, Arcturus Therapeutics announce European Commission approval for Kostaive
2M ago
ARCT
Premium
The Fly
Arcturus Therapeutics appoints Moncef Slaoui as chair designate
2M ago
ARCT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
